Is there a third line option after chemotherapy and TKI failure in advanced non-small cell lung cancer?
Transl Lung Cancer Res
.
2012 Jun;1(2):152-4.
doi: 10.3978/j.issn.2218-6751.2012.06.04.
Authors
Jacques De Grève
1
,
Lore Decoster
1
,
David van Brummelen
1
,
Caroline Geers
1
,
Denis Schallier
1
Affiliation
1
Department of Medical Oncology, Oncologisch Centrum, UZ Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium.
PMID:
25806173
PMCID:
PMC4367571
DOI:
10.3978/j.issn.2218-6751.2012.06.04
No abstract available